Literature DB >> 11113960

Evidence-based medicine as Bayesian decision-making.

D Ashby1, A F Smith.   

Abstract

We review two recent trends: the emergence of evidence-based medicine and the growing use of Bayesian statistics in medical applications. Evidence-based medicine requires an integrated assessment of the available evidence, and associated uncertainty, but there is also an emphasis on decision-making, for individual patients, or at other points in the health-care system. This demands consideration of the values and costs associated with potential outcomes. We argue that the natural statistical framework for evidence-based medicine is a Bayesian approach to decision-making that incorporates an integrated summary of the available evidence and associated uncertainty with assessment of utilities. We outline a practical agenda for further development.

Entities:  

Mesh:

Year:  2000        PMID: 11113960     DOI: 10.1002/1097-0258(20001215)19:23<3291::aid-sim627>3.0.co;2-t

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  26 in total

Review 1.  Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway?

Authors:  Richard J Lilford
Journal:  BMJ       Date:  2003-05-03

Review 2.  Bayesian methods in reporting and managing Australian clinical indicators.

Authors:  Peter P Howley; Stephen J Hancock; Robert W Gibberd; Sheuwen Chuang; Frank A Tuyl
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

Review 3.  The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.

Authors:  Grant H Skrepnek
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  A Growing Consensus for Change in Interpretation of Clinical Research Evidence.

Authors:  Gary B Wilkerson; Craig R Denegar
Journal:  J Athl Train       Date:  2018-03       Impact factor: 2.860

Review 5.  Integration of PKPD relationships into benefit-risk analysis.

Authors:  Francesco Bellanti; Rob C van Wijk; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-07-29       Impact factor: 4.335

6.  Semi-automated volumetric analysis in the NELSON trial for lung cancer screening: is there room for diagnostic experience yet?

Authors:  Giuseppe Bronte; Christian Rolfo
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  Relationship between Student Pharmacist Decision Making Preferences and Experiential Learning.

Authors:  Charlene R Williams; Jacqueline E McLaughlin; Wendy C Cox; Greene Shepherd
Journal:  Am J Pharm Educ       Date:  2016-09-25       Impact factor: 2.047

Review 8.  A statistical framework for applying RNA profiling to chemical hazard detection.

Authors:  Mitchell S Kostich
Journal:  Chemosphere       Date:  2017-08-28       Impact factor: 7.086

9.  Appraising and applying evidence about a diagnostic test during a performance-based assessment.

Authors:  George Bergus; Scott Vogelgesang; Janeta Tansey; Ellen Franklin; Ronald Feld
Journal:  BMC Med Educ       Date:  2004-10-13       Impact factor: 2.463

10.  Bayesian decision analysis for choosing between diagnostic/prognostic prediction procedures.

Authors:  John Kornak; Ying Lu
Journal:  Stat Interface       Date:  2011       Impact factor: 0.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.